Looking Ahead, States Begin Casting Biosimilar Safety Net
By Mari Serebrov
Washington Editor
Washington Editor
While the FDA is still waiting for its first biosimilar application to be submitted, a few states – with the encouragement of patient advocacy groups and the biopharma industry – are already casting a safety net for when interchangeable biologics hit the U.S. market.
